9p21 Locus Polymorphism Is A Strong Predictor of Metabolic Syndrome and Cardiometabolic Risk Phenotypes Regardless of Coronary Heart Disease.

doi:10.3390/genes13122226

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

9p21 Locus Polymorphism Is A Strong Predictor of Metabolic Syndrome and Cardiometabolic Risk Phenotypes Regardless of Coronary Heart Disease.

Genes - 27 Nov 2022

Mobeen Zafar Muhammad, Saqlain Muhammad, Mehmood Raja Asad, Arzoo Shaiq Pakeeza, Javaid Asad Muhammad, Nawaz Shah Muhammad Kausar, Fatima Farah, Valadi Hadi, Nawaz Muhammad, Raja Ghazala Kaukab

Abstract excerpt

The world population is genetically predisposed to metabolic syndrome (MetS) and its components, also known as cardiometabolic risk phenotypes, which can cause severe health complications including coronary heart disease (CHD). Genetic variants in the 9p21 locus have been associated with CHD in a number of populations including Pakistan. However, the role of the 9p21 locus in MetS and cardiometabolic risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Hypertension

Share to Metabolic Syndrome

Share to Obesity

Share to Phenotype

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 36553493
DOI: 10.3390/genes13122226
PMCID: PMC9778176

Provenance

PubMed metadata and Literature Corpus relationships.